Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China
· Delayed Price · Currency is CNY 25.87
-0.06 (-0.23%)
Apr 29, 2026, 3:04 PM CST
SHE:300357 Revenue
Zhejiang Wolwo Bio-Pharmaceutical had revenue of 252.84M CNY in the quarter ending March 31, 2026, with 10.67% growth. This brings the company's revenue in the last twelve months to 1.09B, up 15.91% year-over-year. In the year 2025, Zhejiang Wolwo Bio-Pharmaceutical had annual revenue of 1.06B with 14.81% growth.
Revenue (ttm)
1.09B
Revenue Growth
+15.91%
P/S Ratio
12.46
Revenue / Employee
601.09K
Employees
1,679
Market Cap
13.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.06B | 137.01M | 14.81% |
| Dec 31, 2024 | 925.39M | 77.20M | 9.10% |
| Dec 31, 2023 | 848.19M | -47.83M | -5.34% |
| Jan 1, 2023 | 896.02M | 88.32M | 10.94% |
| Dec 31, 2021 | 807.69M | 171.48M | 26.95% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSPC Hunan Jingfeng Pharmaceutical | 385.54M |
| Aurora Optoelectronics | 465.12M |
| Yifan Pharmaceutical | 5.06B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.11B |
| Shanghai InnoStar Bio-tech | 811.33M |
| GuangYuYuan Chinese Herbal Medicine | 1.44B |
| Nanjing Pharmaceutical Group Company | 54.96B |
| Chongqing Lummy Pharmaceutical | 759.50M |